ALLISON MARQUIS: Open Payments
NPI 1124664248 · CASTLE ROCK, CO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$587 in 25 payments from 10 companies in 2025. Trend: 2023 $1,236 · 2024 $1,146 · 2025 $587
Food & beverage: $487Education: $100
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 4 | $155 |
| UCB, Inc. | 6 | $149 |
| Organogenesis Inc. | 3 | $62 |
| ABBVIE INC. | 2 | $53 |
| Organon LLC | 5 | $43 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 1 | $29 |
| LEO Pharma Inc. | 1 | $28 |
| ConvaTec Inc. | 1 | $28 |
| Incyte Corporation | 1 | $24 |
| Arcutis Biotherapeutics, Inc. | 1 | $15 |
Products named: TREMFYA, Bimzelx, SKYRIZI, PURAPLY WOUND MATRIX, Odomzo, ADBRY, INNOVAMATRIX AC, OPZELURA.
Industry payments across CO — which companies pay providers there.
